HFSA Board Certification Review 2021

Heart Failure Fundamentals (Pre-Recorded)

 

Heart Failure Epidemiology and Risk Factors

Sadiya Khan

 

Pathophysiology I: Cellular and Energetic Considerations

Daniel Burkhoff

 

Pathophysiology II: Hemodynamic, Structural, and Neurohormonal Considerations

Daniel Burkhoff

 

Diagnosis and Clinical Assessment

Mark Drazner

 

Cardio-Oncology for the HF boards

Bonnie Ky

 

Clinico-Pathologic Correlates in Heart Failure/ Images for the Heart Failure Boards

Jon Lomasney

 

Statistics for the HF Board

Brian Claggett

 

Cardiac Transplantation

 

Advanced Heart Failure: Defining the Phenotype and Patient Selection for Advanced Therapies

Nancy Sweitzer

 

Immunology: The Basics, PRA, Sensitization, Crossmatch

Sean Pinney

 

Rejection: Cellular and Antibody Mediated

Sean Pinney

 

Managing Immunosuppression and Drugs

Michelle Kittleson

 

Heart Transplant, Clinical Outcomes and Complications

Michelle Kittleson

 

Q&A Panel I

Akshay Desai, Nancy Sweitzer, Jonathan Rich, Maria Rosa

 

Key Issues in HF Management

 

Hemodynamics in HF I

James Fang

 

Hemodynamics in HF II

James Fang

 

Drug Therapy for Chronic HF I: Focus on established therapies (ACE/ARB/Beta-blocker/MRA/Digoxin/Hydralazine+Nitrates)

Clyde Yancy

 

Drug Therapy for Chronic HF II: Focus on newer therapies (Sacubitril/Valsartan, Ivabradine, SGLT2 inhibitors)

Mark Drazner

 

HFpEF: Epidemiology, Risk Factors, Diagnosis, Management (for the boards)

Sanjiv Shah

 

Pulmonary Hypertension

Jonathan Rich

 

Management of Common Arrhythmias I – Atrial Fib and Flutter

Roderick Tung

 

Management of Common Arrhythmias in HF II

Roderick Tung

 

Device Therapy in Heart Failure I – Sudden Death Prevention

Wendy Tzou

 

Device Therapy in Heart Failure II – CRT

Wendy Tzou

 

Management of the Hospitalized HF Patient

Maria Rosa Costanzo

 

Cardio Renal Failure Interactions in Heart Failure

Jeff Testani

 

Specific Heart Failure Syndromes

 

Specific Etiologies of HF I: Common Etiologies (CAD, ETOH, Peripartum, Myocarditis)

Akshay Desai

 

Specific Etiologies of HF II: Inherited HF syndromes (including HCM, ARVC, and LVNC)

Jane Wilcox

 

Specific Etiologies of HF III: Infiltrative Disorders and Restrictive Cardiomyopathy (Amyloidosis, Sarcoidosis, Hemochromatosis, Fabry)

Sanjiv Shah

 

Q&A Panel II

Akshay Desai, Nancy Sweitzer, Jonathan Rich, Maria Rosa

Guest: James Fang

 

Shock/MCS

 

Cardiogenic Shock Management

Nancy Sweitzer

 

MCS I: Durable MCS Devices and Outcomes

Joseph Rogers

 

MCS II: Temporary Support Devices and ECMO for the Boards

Jennifer Cowger

 

MCS III: MCS Complications and Patient Management

Jennifer Cowger

 

MCS IV: Interactive Shock and Device Management

Daniel Burkhoff, Jennifer Cowger, Joseph Rogers, Nancy Sweitzer

 

Special Topics in HF

 

Assessment of Functional Capacity including cardiopulmonary exercise testing

Gregory Lewis

 

Adult Congenital Heart Disease for the HF Specialist

Eric Krieger

 

Issues in Chronic HF Disease Management (Biomarkers, Remote Monitoring, Lifestyle Interventions)

Akshay Desai

 

Management of Valvular Heart Disease in Heart Failure (including functional MR, low gradient AS, tricuspid regurgitation)

Jane Wilcox

 

Management of Comorbidities in Heart Failure – Diabetes, Sleep Disorders, Iron Deficiency/Anemia, COPD

Maria Rosa Costanzo

 

Q&A Panel III

Akshay Desai, Nancy Sweitzer, Jonathan Rich